As of 2026-09-15, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 80.54 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -55.9%.
The range of the Relative Valuation is 64.90 - 113.55 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.0x - 36.9x | 30.6x |
| Forward P/E multiples | 25.0x - 29.6x | 25.8x |
| Fair Price | 64.90 - 113.55 | 80.54 |
| Upside | -64.4% - -37.8% | -55.9% |
| Date | P/E |